InsiderSignal.AI

InsiderSignal.ai

NTHI - Neonc Technologies Holdings, Inc.

Insider Purchase by Heshmatpour Amir F (Pres, 10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

4 days ago, Heshmatpour Amir F, serving as Pres, 10% owner at Neonc Technologies Holdings, Inc. (NTHI), purchased 10,000 shares at $4.90 per share, for a total transaction value of $48,950.00. Following this transaction, Heshmatpour Amir F now holds 7,562,140 shares of NTHI.

The trade was executed on Friday, April 10, 2026 and publicly disclosed via SEC Form 4 filing on Friday, April 10, 2026, meaning the disclosure happened on the same day as the trade.

Neonc Technologies Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Heshmatpour Amir F

Heshmatpour Amir F

Pres, 10%

Amir F. Heshmatpour is the CEO, Executive Chairman, and President of NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company developing innovative therapeutics for central nervous system cancers using its NEO™ drug platform.[[1]](https://neonc.com/neonc-executive-chairman-assumes-expanded-leadership-role/)[[3]](https://neonc.com/leadership/) Appointed President in April 2025 while retaining his Chairman role, he oversees day-to-day operations to advance clinical programs like NEO212 and NEO100, allowing CEO Dr. Thomas Chen to focus on trials.[[1]](https://neonc.com/neonc-executive-chairman-assumes-expanded-leadership-role/)[[3]](https://neonc.com/leadership/) Heshmatpour brings over 25 years of executive experience in business development, operations, finance, and M&A.[[1]](https://neonc.com/neonc-executive-chairman-assumes-expanded-leadership-role/)[[4]](https://firstwordpharma.com/story/6515903) He founded AFH Holdings & Advisory, leading IPOs over $1.5 billion and private deals exceeding $5 billion; previously founded Metrophone Telecommunications in 1994, growing it to $100 million in revenue via 17 acquisitions.[[1]](https://neonc.com/neonc-executive-chairman-assumes-expanded-leadership-role/) A board member of UCLA Anderson School of Management (12+ years) and Make-A-Wish Foundation, he owns ~7.5 million NTHI shares worth ~$43 million as of April 2026 and sold 38,464 shares in March 2025.[[2]](https://www.gurufocus.com/insider/109316/amir-f-heshmatpour) Motivated personally by family loss to brain cancer, he expanded NeOnc into Israel and UAE for trials and investments.[[5]](https://en.globes.co.il/en/article-the-iranian-businessman-testing-a-cancer-drug-in-israel-1001532408)[[6]](https://www.jpost.com/j-spot/article-888654)

View full insider profile →

Trade Price

$4.90

Quantity

10,000

Total Value

$48,950.00

Shares Owned

7,562,140

Trade Date

Friday, April 10, 2026

4 days ago

SEC Filing Date

Friday, April 10, 2026

HEALTHCAREBIOTECHNOLOGY

About Neonc Technologies Holdings, Inc.

Company Overview

No company information available
View news mentioning NTHI

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5609290

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime